Johnson & Johnson’s and Pfizer Inc.'s Bapineuzumab Might Tackle Alzheimer’s Protein Early On

Wall Street Journal -- Many scientists believe that Alzheimer’s disease is caused in part by a sticky substance called amyloid that clumps in the brain to cause plaques. But scientists also have posited that the amyloid protein could be causing trouble even before it forms plaques, when it is still floating around in cerebrospinal fluid in its so-called soluble form.

MORE ON THIS TOPIC